Tag: emergency contraception market insights

  • Emergency Contraception Market Outlook Through 2030: Understanding The Growth Opportunity

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Emergency Contraception Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

    The emergency contraception market size has experienced robust expansion in recent years. Its projected expansion is from $1.55 billion in 2025 to $1.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth in previous periods include heightened awareness regarding emergency contraception, an increase in contraceptive failure rates, wider reach of retail pharmacy networks, an escalating need for hormonal contraceptives, and successful regulatory approvals for emergency contraceptive pills.

    The emergency contraception market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $2.16 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is attributable to factors such as the increasing uptake of online pharmacy platforms, a rising need for homecare delivery solutions, the development of awareness programs tailored to specific age groups, a growing inclination towards non-hormonal and herbal options, and the launch of products with higher doses and multiple formulations. Key trends expected over this period involve the greater accessibility of over-the-counter emergency contraceptives, a surge in the use of online pharmacies and home delivery services, an enhanced emphasis on awareness initiatives targeting adolescents and adults, the broader availability of high-dose and multi-formulation choices, and increased incorporation of copper intrauterine devices and non-hormonal approaches.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=94977472&type=smp&name=Emergency%20Contraception%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Emergency Contraception Market Growth Drivers: What’s Behind The Acceleration?

    The escalating incidence of unprotected intercourse is anticipated to stimulate the expansion of the emergency contraception market moving ahead. Unprotected intercourse is defined as sexual activity performed without utilizing any type of barrier contraception, such as condoms, or other dependable birth control methods, which places participants at risk for unwanted pregnancies and sexually transmitted infections. The rise in unprotected intercourse is attributed to decreasing condom usage and inconsistent adoption of other contraceptive practices among sexually active individuals, especially young adults and adolescents, which consequently increases the probability of unprotected sexual encounters. Emergency contraception offers a crucial backup option after unprotected intercourse by preventing unintended pregnancies, directly addressing the outcomes of forgotten or absent contraception, and reducing the immediate danger associated with unprotected sexual activity. For example, according to the 2023 National Youth Risk Behavior Survey conducted by the Centers for Control and Prevention, a US-based government agency, in a 2023 survey of U.S. high school students, 32% reported having engaged in sexual intercourse at least once, and 48% indicated they did not use a condom during their most recent sexual encounter. Therefore, the growing rates of unprotected intercourse are fueling the growth of the emergency contraception market.

    Emergency Contraception Market Segment Analysis And Revenue Potential

    The emergency contraception market covered in this report is segmented –

    1) By Product Type: Levonorgestrel, Ulipristal Acetate, Mifepristone, Other Product Types

    2) By Dosage Form: Tablets, Injections, Other Dosage Forms

    3) By Age Group: Adolescents, Adults

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

    5) By End-User: Hospitals, Clinics, Homecare, Other End Users

    Subsegments:

    1) By Levonorgestrel: Single Dose Tablets, Two Dose Tablets, Over The Counter Formulations, Prescription Based Formulations

    2) By Ulipristal Acetate: Single Dose Tablets, Prescription Based Tablets, High Dose Formulations, Low Dose Formulations

    3) By Mifepristone: Low Dose Emergency Use, Combination Regimen Formulations, Prescription Based Tablets, Clinical Setting Formulations

    4) By Other Product Types: Copper Intrauterine Devices, Combined Hormonal Regimens, Non Hormonal Methods, Herbal Based Formulations

    Emergency Contraception Market Trends: What’s Defining The Industry’s Next Phase?

    Leading companies in the emergency contraception market are concentrating on developing innovative products, such as over-the-counter emergency contraceptives, to enhance accessibility and offer swift, effective pregnancy prevention. Over-the-counter emergency contraceptives are oral tablets containing hormones like levonorgestrel that can be acquired without a prescription and assist in preventing pregnancy by postponing ovulation or fertilization when taken shortly after unprotected sexual activity. For instance, in August 2024, Verséa Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, introduced empowered choice, a U.S. Food and Drug Administration–approved over‑the‑counter emergency contraceptive intended to expand accessible options through mainstream retail and online channels. The introduction involved nationwide distribution agreements with major pharmacies and e-commerce platforms, alongside a comprehensive educational campaign designed to increase awareness regarding emergency contraception choices, correct usage, and optimal timing for effectiveness. This initiative aimed to reach a broader audience, lessen the stigma surrounding emergency contraception, and ensure individuals could obtain the product rapidly and discreetly. The product utilizes a simple oral levonorgestrel formulation that guarantees effective emergency pregnancy prevention, is available without a prescription, and grants individuals greater autonomy and flexibility in making reproductive health decisions.

    Emergency Contraception Market Leading Players And Competitive Positioning

    Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.

    View The Full Emergency Contraception Market Report:

    https://thebusinessresearchcompany.com/report/emergency-contraception-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Emergency Contraception Market Regional Split: Which Areas Are Fueling Growth?

    North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emergency contraception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Emergency Contraception Market Forecast To Achieve $2.16 Billion By 2030 At 6.9% CAGR

    Global Emergency Contraception Market Forecast To Achieve $2.16 Billion By 2030 At 6.9% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Emergency Contraception Market Expected To Scale Between 2026 And 2030?

    The emergency contraception market has demonstrated robust growth in recent years. The market is anticipated to expand from $1.55 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. This historical growth can be ascribed to several factors, including heightened awareness of emergency contraception, an increase in contraceptive failure rates, the expansion of retail pharmacy networks, growing demand for hormonal contraceptives, and regulatory approvals for emergency contraceptive pills.

    The emergency contraception market is projected to experience substantial growth over the next few years. It is expected to expand to $2.16 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.9%. This anticipated growth is driven by factors such as the increasing use of online pharmacy platforms, rising demand for homecare delivery, the expansion of awareness programs tailored to specific age groups, a growing preference for non-hormonal and herbal options, and the introduction of high-dose and multi-formulation products. Significant trends during this forecast period include the enhanced availability of over-the-counter emergency contraceptives, the escalating adoption of online pharmacies and home delivery services, a heightened focus on awareness initiatives for adolescents and adults, the broadening of high-dose and multi-formulation choices, and the increasing incorporation of copper intrauterine devices and non-hormonal methods.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample_request?id=27330367&type=smp&name=Emergency%20Contraception%20Market%20Report%202026

    What Significant Factors Are Influencing The Emergency Contraception Market Expansion?

    The increasing prevalence of unprotected intercourse is anticipated to propel the growth of the emergency contraception market in the future. Unprotected intercourse defines sexual activity conducted without employing any form of barrier contraception, such as condoms, or other dependable birth control methods, consequently exposing participants to the danger of unintended pregnancy and sexually transmitted infections. This rise in unprotected intercourse stems from reduced condom usage and inconsistent adoption of alternative contraceptive methods among sexually active individuals, notably young adults and adolescents, which heightens the probability of unprotected sexual encounters. Emergency contraception presents a crucial safety measure following unprotected intercourse by preventing unintended pregnancies, directly addressing the outcomes of missed or absent contraception and diminishing the immediate risk associated with unprotected sexual activity. For instance, according to the 2023 National Youth Risk Behavior Survey conducted by the Centers for Disease Control and Prevention, a US-based government agency, a 2023 survey of U.S. high school students revealed that 32% reported engaging in sexual intercourse at least once, and 48% stated they did not use a condom during their most recent sexual encounter. Therefore, the escalating rates of unprotected intercourse are driving the growth of the emergency contraception market.

    How Is Segmentation Applied In The Emergency Contraception Market Segment Analysis?

    The emergency contraception market covered in this report is segmented –

    1) By Product Type: Levonorgestrel, Ulipristal Acetate, Mifepristone, Other Product Types

    2) By Dosage Form: Tablets, Injections, Other Dosage Forms

    3) By Age Group: Adolescents, Adults

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

    5) By End-User: Hospitals, Clinics, Homecare, Other End Users

    Subsegments:

    1) By Levonorgestrel: Single Dose Tablets, Two Dose Tablets, Over The Counter Formulations, Prescription Based Formulations

    2) By Ulipristal Acetate: Single Dose Tablets, Prescription Based Tablets, High Dose Formulations, Low Dose Formulations

    3) By Mifepristone: Low Dose Emergency Use, Combination Regimen Formulations, Prescription Based Tablets, Clinical Setting Formulations

    4) By Other Product Types: Copper Intrauterine Devices, Combined Hormonal Regimens, Non Hormonal Methods, Herbal Based Formulations

    What Trends Are Shaping The Future Of The Emergency Contraception Market?

    Leading companies in the emergency contraception market are concentrating on developing innovative products, such as over-the-counter emergency contraceptives, to enhance accessibility and offer swift, effective pregnancy prevention. These non-prescription emergency contraceptives are oral pills containing hormones like levonorgestrel, available without a prescription, and function to prevent pregnancy by delaying ovulation or fertilization when taken shortly after unprotected intercourse. For instance, in August 2024, Verséa Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, launched empowered choice, a U.S. Food and Drug Administration–approved over-the-counter emergency contraceptive intended to broaden accessible options across mainstream retail and online platforms. The introduction included nationwide distribution collaborations with major pharmacies and e-commerce channels, complemented by a comprehensive educational initiative to raise awareness regarding emergency contraception choices, correct usage, and optimal timing for effectiveness. This effort aimed to reach a wider audience, reduce the stigma surrounding emergency contraception, and ensure individuals could obtain the product quickly and discreetly. The product features a simple oral levonorgestrel formulation, assuring effective emergency pregnancy prevention, can be used without a prescription, and offers individuals greater autonomy and flexibility in their reproductive health decision-making.

    Who Are The Companies Participating In The Emergency Contraception Market Environment?

    Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.

    Get The Full Emergency Contraception Market Report:

    https://www.thebusinessresearchcompany.com/report/emergency-contraception-market-report

    Which Region Accounts For The Largest Portion Of The Emergency Contraception Market?

    North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emergency contraception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Emergency Contraception Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/Customise?id=27330367&name=Emergency%20Contraception%20Market%20Report%202026&type=smp

    Browse Through More Reports Similar to the Global Emergency Contraception Market 2026, By The Business Research Company

    adeno-associated virus (avv) vectors in gene therapy market report 2026

    https://www.thebusinessresearchcompany.com/report/adeno-associated-virus-avv-vectors-in-gene-therapy-global-market-report

    gastric cancer therapy market report 2026

    https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report

    over the counter (otc) drugs market report 2026

    https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model